P3 Health Partners (PIII) Company Future Revenue

Symbol and logo of brand P3 Health Partners Inc. (PIII)

P3 Health Partners Inc. generates revenue through comprehensive health management via value-based care partner networks. Stable demand and US government programs provide the business with high macro resilience, although strict cost optimization remains necessary to compete for margins against industry behemoths. Future sales volumes objectively link revenue forecasts to capitalization, where the 1.55 mark serves as a current indicator.

PIII (P3 Health Partners Inc.) Projected Sales Volume history from 07/04/2022 to 11/14/2026

Metric breakdowns and analytics for P3 Health (PIII)

- market value and analyst target forecast:
- market capitalization details:
Comprehensive company analysis:P3 Health Partners Inc.
Signature product of P3 Health Partners, Inc.

This indicator determines the expected revenue of P3 Health Partners Inc. (PIII) amid strict government regulation of US healthcare. The metric is based on market quote consensus and the order book balance, measuring future trading volume. Analyzing the valuation of the organization's prospective sales allows for the identification of hidden opportunities during local downturns. The stability of flows here confirms the resilience of the unique risk management model for elderly patients. Forecast transparency minimizes uncertainty when dealing with government contracts.

Competitors of P3 Health Partners Inc.

Company Future Sales Volume HCA (HCA Inc.)|THC - Company Expected Sales Volume|Projected Sales Volume FMS (freseniusmedicalcare.com)|Solventum Inc. - Company Projected Revenue|EHC - Company Projected Revenue|Company Future Revenue UHS (Universal Health Services, Inc.)|DVA (DaVita) - Company Future Sales Volume|RDNT: Company Projected Revenue Volume|Company Future Sales Volume OPCH|Company Expected Sales Volume Surgery Partners, Inc. SGRY|Company Future Sales Volume PINC (Premier, Inc.)|EYE (National Vision) - Company Future Revenue|Projected Sales Volume PGNY (Progyny Inc)|Ardent Health Partners (ARDT) - Company Expected Sales Volume|Select Medical Inc. - Projected Sales Volume|Company Expected Sales Volume Apollo Medical Holdings|MD: Projected Sales Volume|Company Future Sales Volume US Physical Therapy|Company Future Sales Volume PNTG|Organogenesis Holdings Inc. (ORGO) - Company Future Sales|Company Future Sales Volume NUTX (Nutex Health Corp)|AUNA (Auna Health) - Company Future Revenue|Company Projected Revenue sbc-holdings.com SBC|evolus.com - Company Projected Revenue|Community Health Systems, Inc. - Projected Sales Volume|SKIN: Company Projected Revenue|MDWD: Projected Sales Volume|BTMD: Company Projected Revenue Volume|Company Future Sales Volume JYNT|Company Expected Sales Volume DocGo Inc. DCGO|Company Future Sales Volume GANX (Gain Therapeutics, Inc.)|EUDA - Company Expected Sales Volume|Company Projected Revenue Basel Medical BMGL|CollPlant Biotechnologies (CLGN) - Company Expected Sales Volume|CUPR: Company Future Sales Volume|Company Future Sales Concord Medical Services CCM|AMS (American Shared Hospital) - Company Future Sales Volume|Company Revenue Forecast MRM|Company Projected Revenue avalon-globocare.com|Projected Sales Volume DIH Holding US Inc.|Company Projected Revenue Carmell Therapeutics (XAGE)|newgenivf.com - Company Revenue Forecast|Company Projected Revenue ATI Physical Therapy Inc. ATIP|CMAX: Company Revenue Forecast|kindlymd.com - Projected Sales Volume|Company Expected Sales Volume ModivCare Corp|NVOS (Novo Integrated Sciences) - Company Future Sales Volume|SunLink Health Systems Inc. - Company Future Revenue|Company Future Sales Volume BACK